|

Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma

RECRUITINGN/ASponsored by Foundation University Islamabad
Actively Recruiting
PhaseN/A
SponsorFoundation University Islamabad
Started2024-06-18
Est. completion2025-01-01
Eligibility
Age18 Years – 45 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06609941

Summary

Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exercises help to manage hyperventilation often seen in asthmatic patients. To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications.

Eligibility

Age: 18 Years – 45 YearsHealthy volunteers accepted
Inclusion Criteria:

* Adults: aged (18-45 years)
* Gender: Both males and females
* Grade1- Grade 4 on Modified MRC dyspnea scale
* Asthma severity classes (intermediate, mild persistent and moderate persistent asthma) acc. to NAEPP national asthma education and prevention program guidlin

Exclusion Criteria:

* Patients having acute exacerbation of COPD or status asthmaticus
* Patients diagnosed with acute infections
* Patients unable to follow command/ instructions
* Asthma patients with \>40 sec control pause duration
* Patients who fall in red zone of asthma action plan (PEFR \< 50%)

Conditions2

AsthmaBronchial Asthma

Browse More Trials

Asthma trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.